The UK has a unique asset: millions of longitudinal health records built over decades across a diverse population. From births and vaccinations to cancer diagnoses and mental health treatments, this data holds extraordinary potential to improve medical research and accelerate the development of new
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, points to a new challenge to the MedTech sector of deliver devices to tackle substance addiction. The UK government has opened a major new funding opportunity for innovators
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, reviews the trends from the latest approvals data from the medical devices regulator. The UK’s medical device sector is entering a period of unprecedented momentum, with new
UK patients could be among the first in the world to benefit from breakthrough medical devices, as clinical investigations reach their highest level on record in 2025. New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show a 17% rise in approved clinical investigations
For many MedTech and digital health innovators, international expansion feels like a natural next step. New markets promise larger patient populations, new customers, and new and larger opportunities for growth. However, the reality of entering global healthcare systems is rarely straightforward. Ea
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, identifies a new consultation launched by the UK’s MedTech regulator. The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on pro
“Running a system as large and complex as the NHS centrally is an experiment which has run its course.” The MTG sat down with Sebastian Rees, Head of Health at the IPPR (Institute for Public Policy Research) to discuss our new report on accountability. From the Ten Year Health Plan to the abolition
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, reports on the latest steps by government agencies to drive the adoption of innovative MedTech. Medical device innovators across the UK are set to benefit from a major shift
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, highlights the latest efforts by government and its agencies to engage with MedTech suppliers, SMEs and their trade associations. The Department of Health and Social Care (DH
The MTG sat down with David Lawson to reflect on three years guiding the government’s medical technology strategy and what industry, patients and stakeholders need to know about the developments underway to support the NHS’s pivot to technology under the Ten Year Plan. You’ve been in the role of Dir
Chris Whitehouse, a public affairs consultant and expert on medical technology policy and regulation at Whitehouse Communications, reports on progress in the delivery of value based procurement and warns that industry must urgently step up its preparations. Value based procurement (VBP) will be deli
One of the biggest changes to the operation of the NHS in England is coming soon, but with little fanfare to date for the policies developed and about to be delivered by Labour’s health ministers. We should be making more of the coming change. As the NHS Ten Year Plan acknowledged, when buying thing
